346 related articles for article (PubMed ID: 32725881)
1. The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
Bami S; Vagrecha A; Soberman D; Badawi M; Cannone D; Lipton JM; Cron RQ; Levy CF
Pediatr Blood Cancer; 2020 Nov; 67(11):e28581. PubMed ID: 32725881
[TBL] [Abstract][Full Text] [Related]
2. Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.
Eloseily EM; Weiser P; Crayne CB; Haines H; Mannion ML; Stoll ML; Beukelman T; Atkinson TP; Cron RQ
Arthritis Rheumatol; 2020 Feb; 72(2):326-334. PubMed ID: 31513353
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
4. Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
Charlesworth JEG; Kavirayani A
Eur J Haematol; 2023 Sep; 111(3):458-476. PubMed ID: 37344166
[TBL] [Abstract][Full Text] [Related]
5. Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis.
Lee BJ; Cao Y; Vittayawacharin P; É'Leima G; Rezk S; Reid J; Brem EA; Ciurea SO; Kongtim P
Eur J Haematol; 2023 Sep; 111(3):477-484. PubMed ID: 37385631
[TBL] [Abstract][Full Text] [Related]
6. Systemic and Nodular Hyperinflammation in a Patient with Refractory Familial Hemophagocytic Lymphohistiocytosis 2.
Segal JE; Daley JD; Barnum JL; Salgado CM; Reyes-Mugica M; Schneider C; Gumus S; Thakrar D; Allen SW; Canna SW
J Clin Immunol; 2021 Jul; 41(5):987-991. PubMed ID: 33570715
[TBL] [Abstract][Full Text] [Related]
7. Safe usage of anakinra and dexamethasone to treat refractory hemophagocytic lymphohistiocytosis secondary to acute disseminated histoplasmosis in a patient with HIV/AIDS.
Ocon AJ; Bhatt BD; Miller C; Peredo RA
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978596
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
[TBL] [Abstract][Full Text] [Related]
9. Anakinra for the treatment of adult secondary HLH: a retrospective experience.
Naymagon L
Int J Hematol; 2022 Dec; 116(6):947-955. PubMed ID: 35948764
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study.
Xu XJ; Wang HS; Ju XL; Xiao PF; Xiao Y; Xue HM; Shi HY; Gao YJ; Jia GC; Li XR; Zhao WH; Wang NL; Tang YM;
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27781387
[TBL] [Abstract][Full Text] [Related]
11. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
12. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
13. Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination.
Hieber ML; Sprute R; Eichenauer DA; Hallek M; Jachimowicz RD
Infection; 2022 Oct; 50(5):1399-1404. PubMed ID: 35218512
[TBL] [Abstract][Full Text] [Related]
14. A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Kumar B; Aleem S; Saleh H; Petts J; Ballas ZK
J Clin Immunol; 2017 Oct; 37(7):638-643. PubMed ID: 28871523
[TBL] [Abstract][Full Text] [Related]
15. Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children.
Charlesworth JEG; Wilson S; Qureshi A; Blanco E; Mitchell A; Segal S; Kelly D; Weitz J; O'Shea D; Bailey K; Kavirayani A
Pediatr Blood Cancer; 2021 Sep; 68(9):e29102. PubMed ID: 34114322
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostics and treatment of hemophagocytic lymphohistiocytosis].
Eichenauer DA; Böll B
Inn Med (Heidelb); 2023 Nov; 64(11):1077-1084. PubMed ID: 37855882
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis: A case report and review of the literature.
Nusshag C; Morath C; Zeier M; Weigand MA; Merle U; Brenner T
Medicine (Baltimore); 2017 Dec; 96(50):e9283. PubMed ID: 29390386
[TBL] [Abstract][Full Text] [Related]
18. Successful use of subcutaneous anakinra in hemophagocytic lymphohistiocytosis precipitated by candidiasis in a patient with systemic lupus erythematosus: A case report and description of a novel therapeutic regimen.
Xu G; Islam ST; Makarie-Rofail L; Barnsley L; Limaye S
Int J Rheum Dis; 2023 Nov; 26(11):2284-2287. PubMed ID: 37150523
[TBL] [Abstract][Full Text] [Related]
19. Intravenous administration of anakinra in children with macrophage activation syndrome.
Phadke O; Rouster-Stevens K; Giannopoulos H; Chandrakasan S; Prahalad S
Pediatr Rheumatol Online J; 2021 Jun; 19(1):98. PubMed ID: 34187503
[TBL] [Abstract][Full Text] [Related]
20. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.
Bergsten E; Horne A; Aricó M; Astigarraga I; Egeler RM; Filipovich AH; Ishii E; Janka G; Ladisch S; Lehmberg K; McClain KL; Minkov M; Montgomery S; Nanduri V; Rosso D; Henter JI
Blood; 2017 Dec; 130(25):2728-2738. PubMed ID: 28935695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
